Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant.
Pons-Faudoa FP, Trani ND, Sizovs A, Shelton KA, Momin Z, Bushman LR, Xu J, Lewis DE, Demaria S, Hawkins T, Rooney JF, Marzinke MA, Kimata JT, Anderson PL, Nehete PN, Arduino RC, Sastry KJ, Grattoni A.
Pons-Faudoa FP, et al. Among authors: kimata jt.
Pharmaceutics. 2020 Oct 17;12(10):981. doi: 10.3390/pharmaceutics12100981.
Pharmaceutics. 2020.
PMID: 33080776
Free PMC article.